MedTrace Logo

Occult HCV Infection After DAAD Treatment in Haemodialysis Patients

NCT04719338 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2022-04-15

No results posted yet for this study

Summary

This research aims to evaluate the prevalence and predictors of Occult HCV among hemodialysis (HD) patients who achieved 24 weeks sustained virological response (SVR) after treatment with direct-acting antiviral agents (DAA) by detection of viral RNA in their peripheral blood mononuclear cells.

Conditions

  • Hepatitis C

Interventions

DIAGNOSTIC_TEST

presence of HCV RNA in peripheral blood mononuclear cells (PBMCs) .

samples of peripheral blood from each patient into EDTA tube will be collected and tested for HCV RNA in peripheral blood mononuclear cells (PBMCs) .

Sponsors & Collaborators

  • Alexandria University

    lead OTHER

Principal Investigators

  • Mohamed Mamdouh Elsayed, MD · Lecturer of Nephrology & Internal Medicine, Faculty of medicine, Alexandria University

  • Shady F Abouelnaga, MD · fellow of Clinical and Chemical Pathology Department, Alexandria University Hospitals

  • Hend N Abd Elmoteleub, MD · Lecturer of Hepatolgy and Internal Medicine Department, Faculty of Medicine, Alexandria University

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2021-08-01
Completion
2021-10-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04719338 on ClinicalTrials.gov